Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has strengthened its balance sheet with the receipt of a A$3.67 million income tax refund from the Australian Taxation Office (ATO), adding further non-dilutive funding as the company advances its synthetic anti-infective pipeline toward key Phase 3 clinical milestones.
The refund relates to the financial year ended June 30, 2025, and comprises A$3.57 million in overseas research and development expenditure, plus A$95,826 in interest paid by the ATO.
Nexus Minerals Ltd (ASX:NXM) (Nexus Minerals Ltd (ASX:NXM)) has strengthened the case for a maiden resource at the Clement Prospect within its Wallbrook Gold Project in Western Australia, after final reverse circulation (RC) assays returned broad, high-grade gold intercepts and confirmed the system remains open at depth.
The latest results cover the final 23 drill holes and four drill hole extensions from Clement, representing 4,239 metres of drilling.
The S&P/ASX Small Ordinaries Index (XSO) edged lower in the latest session, slipping 7.50 points, or 0.22%, to 3,424.90.
The move extended recent weakness across the junior end of the market, with the index down 55.10 points, or 1.58%, over the past five trading days.
Shares in Celsius Resources Ltd (ASX:CLA, AIM:CLA, FRA:FX8) jumped 78% to 0.008p after the company agreed to sell its Namibian cobalt-copper project to a subsidiary of Chinese mining giant Chinalco for $15 million.
Celsius, an Australian and London-listed explorer, has signed a binding agreement to sell its 95% interest in the Opuwo project in north-western Namibia to Chinalco (Xiong'an) Mining.
Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the sulfur battery company, has appointed Matthew Wood as chief executive as it shifts from technology development towards commercial scale-up.
He replaces John Wood, who retires from his full-time executive role with immediate effect and steps down from the board after a successful tenure.
MLG OZ LTD (ASX:MLG) has been awarded a A$70 million open pit mining and crushing contract by DEVELOP GLOBAL LTD (ASX:DVP), marking a key step toward first lithium production and cashflow from the Pioneer Dome Lithium Project in Western Australia’s Eastern Goldfields.
The contract covers the Cade Pit, the inaugural mining stage at Pioneer Dome, and is expected to run for about 12 months, with MLG providing drill and blast, load and haul, crushing and screening, and other supporting surface activities.
GCM Corp (ASX:GCM) has signed a binding 24-month Joint Development Agreement (JDA) with China-based thermal management manufacturer Shenzhen Wanwei Heat Conduction Technology Co., Ltd. (ALVC) to develop an integrated thermal management product combining ALVC’s vapour chamber technology with GCM’s VHD heat sink platform.
The agreement marks a third-party selection of GCM’s VHD technology, with ALVC choosing the company’s heat sink solution as an alternative to incumbent aluminium products after assessing its thermal performance characteristics.
Environmental Clean Technologies Ltd (ASX:ECT, OTC:ECTHF) has submitted performance data for its Rapid Electrothermal Mineralisation (REM) technology to the United States Environmental Protection Agency, positioning the process as a potential solution for the safe destruction and disposal of PFAS “forever chemicals”.
The submission was made in response to the EPA’s Interim Guidance on the destruction and disposal of PFAS, a consultation opportunity that opens only once every four years. ECT said its submission presents REM against the EPA’s Section 5 evaluation framework, including technology readiness, destruction efficacy, fluorine mass balance, byproduct safety and regulatory relevance.
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its ongoing Phase 1b azer-cel trial, marking an early clinical signal in a patient group with limited remaining treatment options.
The first patient in the cohort, who had follicular lymphoma and had previously failed BTKi therapy, achieved a complete response at the Day 28 assessment.
Peak Processing Ltd (ASX:PKP) has secured its first US brand-partner manufacturing agreement, signing a three-year exclusive deal to produce Fryday Kush® THC beverages across 13 US states.
The agreement, struck through wholly owned subsidiary Peak USA Inc. with BTAB Solutions Inc., gives Peak exclusive manufacturing rights for designated Fryday Kush THC beverage products in its US operating territory. The arrangement is binding, effective immediately and has no material conditions precedent.
Cyprium Metals Ltd (ASX:CYM, OTCQB:CYPMF) last week outlined strong quarterly progress at its Nifty Copper Complex, with the company remaining on track for first cathode production in the September quarter of 2026.
Executive chairman Matt Fifield said the phase one restart is advancing steadily, with the project now approximately halfway complete in terms of planned hours and budget. He noted that significant progress had been made on heap leach infrastructure, while key capital equipment had begun arriving on site. Fifield described the team as “firing” despite a more complex global operating environment.
Nova Minerals Corp (ASX:NVA, NYSE-A:NVA) high-grade gold concentrate of up to 26.7 g/t from flotation test work on low-grade ore from the Korbel deposit at its Estelle Gold and Critical Minerals Project in Alaska.
During the program, the company highlighted gold recoveries consistently above 95% at Korbel.
Australia has emerged as one of the world’s best-prepared economies for the AI-driven future of work, ranking second globally in the QS World Future Skills Index 2027.
The index, released by higher education analytics firm QS Quacquarelli Symonds, assesses how well economies are developing, aligning and applying skills for a rapidly changing labour market. Australia finished behind only the United States, with a final score of 97.5, ahead of the United Kingdom, Germany and Canada.
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has expanded the humanitarian rollout of its nerve repair device, Remplir™, in Ukraine, following growing use of the product for severe peripheral nerve injuries caused by the ongoing conflict.
The regenerative medicine company said additional devices were now being shipped to Ukraine through a coordinated philanthropic initiative, after an initial deployment in April 2025 supported battlefield trauma programs.